{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:03:24Z","timestamp":1793394204507,"version":"4.5.0"},"reference-count":118,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T00:00:00Z","timestamp":1694304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Antibiotics have played a crucial role in the reduction in the incidence of TB globally as evidenced by the fact that before the mid-20th century, the mortality rate within five years of the onset of the disease was 50%. The use of antibiotics has eliminated TB as a devastating disease, but the challenge of resistance to anti-TB drugs, which had already been described at the time of the introduction of streptomycin, has become a major global issue in disease management. Mismanagement of multidrug-resistant tuberculosis (MDR-TB) cases, resulting from intermittent drug use, prescription errors, and non-compliance of patients, has been identified as a critical risk factor for the development of extensively drug-resistant tuberculosis (XDR-TB). Antimicrobial resistance (AMR) in TB is a multi-factorial, complex problem of microbes evolving to escape antibiotics, the gradual decline in antibiotic development, and different economic and social conditions. In this review, we summarize recent advances in our understanding of how Mycobacterium tuberculosis evolves drug resistance. We also highlight the importance of developing shorter regimens that rapidly reach bacteria in diverse host environments, eradicating all mycobacterial populations and preventing the evolution of drug resistance. Lastly, we also emphasize that the current burden of this ancient disease is driven by a combination of complex interactions between mycobacterial and host factors, and that only a holistic approach that effectively addresses all the critical issues associated with drug resistance will limit the further spread of drug-resistant strains throughout the community.<\/jats:p>","DOI":"10.3390\/microorganisms11092277","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:05:17Z","timestamp":1694423117000},"page":"2277","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis"],"prefix":"10.3390","volume":"11","author":[{"given":"Giuseppe","family":"Mancuso","sequence":"first","affiliation":[{"name":"Mycobacteriology Unit, Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Midiri","sequence":"additional","affiliation":[{"name":"Mycobacteriology Unit, Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"De Gaetano","sequence":"additional","affiliation":[{"name":"Mycobacteriology Unit, Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ponzo","sequence":"additional","affiliation":[{"name":"Mycobacteriology Unit, Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Biondo","sequence":"additional","affiliation":[{"name":"Mycobacteriology Unit, Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Shuaib, Y.A., Utpatel, C., Kohl, T.A., Barilar, I., Diricks, M., Ashraf, N., Wieler, L.H., Kerubo, G., Mesfin, E.A., and Diallo, A.B. (2022). Origin and Global Expansion of Mycobacterium tuberculosis Complex Lineage 3. Genes, 13.","DOI":"10.3390\/genes13060990"},{"key":"ref_2","first-page":"000477","article-title":"Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history","volume":"7","author":"Coscolla","year":"2021","journal-title":"Microb. Genom."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Silva, M.L., Ca, B., Osorio, N.S., Rodrigues, P.N.S., Maceiras, A.R., and Saraiva, M. (2022). Tuberculosis caused by Mycobacterium africanum: Knowns and unknowns. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010490"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"126674","DOI":"10.1016\/j.micres.2020.126674","article-title":"Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery","volume":"246","author":"Kanabalan","year":"2021","journal-title":"Microbiol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3201\/eid1608.100314","article-title":"Novel Mycobacterium tuberculosis complex pathogen, M. mungi","volume":"16","author":"Alexander","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3201\/eid1804.110888","article-title":"Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies","volume":"18","author":"Rahim","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.tube.2013.09.005","article-title":"Non-human sources of Mycobacterium tuberculosis","volume":"93","author":"Ghodbane","year":"2013","journal-title":"Tuberculosis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1111\/j.1365-2672.1996.tb04827.x","article-title":"The biology of the genus Mycobacterium","volume":"25","author":"Grange","year":"1996","journal-title":"Soc. Appl. Bacteriol. Symp. Ser."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0034-5288(02)00145-5","article-title":"The transmission of Mycobacterium bovis infection to cattle","volume":"74","author":"Phillips","year":"2003","journal-title":"Res. Vet. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/JCM.01268-08","article-title":"\u201cMycobacterium canettii\u201d isolated from a human immunodeficiency virus-positive patient: First case recognized in the United States","volume":"47","author":"Somoskovi","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tim.2011.07.002","article-title":"A role for systems epidemiology in tuberculosis research","volume":"19","author":"Comas","year":"2011","journal-title":"Trends Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1038\/s41598-021-90568-x","article-title":"Assessment of closely related Mycobacterium tuberculosis variants with different transmission success and in vitro infection dynamics","volume":"11","author":"Abascal","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fimmu.2019.00528","article-title":"Mycobacterial Evolution Intersects With Host Tolerance","volume":"10","author":"Saelens","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ma, J., Vongpradith, A., Ledesma, J.R., Novotney, A., Yi, S., Lim, K., Hay, S.I., Murray, C.J.L., and Kyu, H.H. (2022). Progress towards the 2020 milestones of the end TB strategy in Cambodia: Estimates of age and sex specific TB incidence and mortality from the Global Burden of Disease Study 2019. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07891-5"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.15585\/mmwr.mm7012a4","article-title":"Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets\u2014Worldwide, 2019","volume":"70","author":"Fukunaga","year":"2021","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_16","first-page":"E9","article-title":"The history of tuberculosis: From the first historical records to the isolation of Koch\u2019s bacillus","volume":"58","author":"Barberis","year":"2017","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_17","first-page":"E3","article-title":"The paleopathological evidence on the origins of human tuberculosis: A review","volume":"61","author":"Buzic","year":"2020","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hershkovitz, I., Donoghue, H.D., Minnikin, D.E., Besra, G.S., Lee, O.Y., Gernaey, A.M., Galili, E., Eshed, V., Greenblatt, C.L., and Lemma, E. (2008). Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003426"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Holloway, K.L., Link, K., Ruhli, F., and Henneberg, M. (2013). Skeletal lesions in human tuberculosis may sometimes heal: An aid to palaeopathological diagnoses. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062798"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20190583","DOI":"10.1098\/rstb.2019.0583","article-title":"\u2018TB or not TB\u2019: The conundrum of pre-European contact tuberculosis in the Pacific","volume":"375","author":"McDonald","year":"2020","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.1038\/s41598-023-38707-4","article-title":"Integer time series models for tuberculosis in Africa","volume":"13","author":"Ojo","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_22","first-page":"196","article-title":"Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882","volume":"20","author":"Cambau","year":"2014","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/313562","article-title":"Old Testament biblical references to tuberculosis","volume":"29","author":"Daniel","year":"1999","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1590\/abd1806-4841.20154262","article-title":"Hieronymi Fracastorii: The Italian scientist who described the \u201cFrench disease\u201d","volume":"90","author":"Pesapane","year":"2015","journal-title":"An. Bras. De Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"de Pee, S., Taren, D., and Bloem, M. (2017). Nutrition and Health in a Developing World, Humana Press.","DOI":"10.1007\/978-3-319-43739-2"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/0974-777X.81691","article-title":"Tuberculosis: Current situation, challenges and overview of its control programs in India","volume":"3","author":"Sandhu","year":"2011","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ja.2014.108","article-title":"From milk to rifampicin and back again: History of failures and successes in the treatment for tuberculosis","volume":"67","author":"Riva","year":"2014","journal-title":"J. Antibiot."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"L412","DOI":"10.1152\/ajplung.00217.2021","article-title":"Latent tuberculosis testing through the ages: The search for a sleeping killer","volume":"322","author":"Kestler","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.2012.01002.x","article-title":"Purified protein derivatives of tuberculin--past, present, and future","volume":"66","author":"Yang","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpp.2021.04.005","article-title":"Was the rise of TB contemporaneous with the industrial revolution? Epidemiological evolution of TB in France (17th\u201320th centuries) inferred from osteoarchaeological and historical archives","volume":"34","author":"Dutour","year":"2021","journal-title":"Int. J. Paleopathol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tripp, L., and Sawchuk, L.A. (2017). Insights into secular trends of respiratory tuberculosis: The 20th century Maltese experience. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183296"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3389\/fphar.2017.00689","article-title":"Addressing the Challenges of Tuberculosis: A Brief Historical Account","volume":"8","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/07853890310005713","article-title":"The world-wide increase in tuberculosis: How demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis","volume":"35","author":"Davies","year":"2003","journal-title":"Ann. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/003335490712200517","article-title":"Tuberculosis control: Challenges of an ancient and ongoing epidemic","volume":"122","author":"Cummings","year":"2007","journal-title":"Public Health Rep."},{"key":"ref_35","first-page":"889","article-title":"The re-emergence of tuberculosis: What have we learnt from molecular epidemiology?","volume":"19","author":"Borgdorff","year":"2013","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.pu.15.050194.001511","article-title":"The re-emergence of tuberculosis","volume":"15","author":"Porter","year":"1994","journal-title":"Annu. Rev. Public Health"},{"key":"ref_37","first-page":"487","article-title":"The re-emergence of tuberculosis: The endemia of multiple-antibiotic-resistant strains","volume":"87","author":"Rossi","year":"1996","journal-title":"Recent. Progress. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002030-199704000-00014","article-title":"The spread of AIDS and the re-emergence of tuberculosis in Catalonia, Spain","volume":"11","author":"Maguire","year":"1997","journal-title":"Aids"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3201\/eid2707.210557","article-title":"Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi","volume":"27","author":"Soko","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2105\/AJPH.2010.199505","article-title":"The social determinants of tuberculosis: From evidence to action","volume":"101","author":"Hargreaves","year":"2011","journal-title":"Am. J. Public Health"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwv176","article-title":"Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis","volume":"183","author":"Zwerling","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2174\/156802611795429158","article-title":"Lessons from seven decades of antituberculosis drug discovery","volume":"11","author":"Barry","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1086\/651491","article-title":"Extensively drug-resistant tuberculosis: \u201cThere must be some kind of way out of here\u201d","volume":"50","author":"Cegielski","year":"2010","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e30405","DOI":"10.1097\/MD.0000000000030405","article-title":"Diagnosis and treatment of tuberculosis in adults with HIV","volume":"101","author":"Yang","year":"2022","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0038-1651492","article-title":"Global Epidemiology of Tuberculosis","volume":"39","author":"Glaziou","year":"2018","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_46","first-page":"S26","article-title":"The WHO Global Tuberculosis 2021 Report\u2014Not so good news and turning the tide back to End TB","volume":"124","author":"Chakaya","year":"2022","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0956462421992257","article-title":"HIV-associated tuberculosis","volume":"32","author":"Hamada","year":"2021","journal-title":"Int. J. STD AIDS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1126429","DOI":"10.3389\/fpubh.2022.1126429","article-title":"Editorial: Updates on tuberculosis control and management","volume":"10","author":"Cai","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_49","unstructured":"Holmes, K.K., Bertozzi, S., Bloom, B.R., and Jha, P. (2017). Major Infectious Diseases, The International Bank for Reconstruction and Development\/The World Bank. [3rd ed.]."},{"key":"ref_50","first-page":"S7","article-title":"Global Tuberculosis Report 2020\u2014Reflections on the Global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12701\/yujm.2020.00626","article-title":"Diagnosis and treatment of multidrug-resistant tuberculosis","volume":"37","author":"Jang","year":"2020","journal-title":"Yeungnam Univ. J. Med."},{"key":"ref_52","unstructured":"WHO (2023). W.H.O. Tuberculosis, WHO."},{"key":"ref_53","first-page":"259","article-title":"Patient, Diagnosis, and Treatment Delays Among Tuberculosis Patients Before and During COVID-19 Epidemic\u2014China, 2018\u20132022","volume":"5","author":"Li","year":"2023","journal-title":"China CDC Wkly."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2213-2600(22)00092-3","article-title":"The intersecting pandemics of tuberculosis and COVID-19: Population-level and patient-level impact, clinical presentation, and corrective interventions","volume":"10","author":"Dheda","year":"2022","journal-title":"Lancet. Respir. Med."},{"key":"ref_55","unstructured":"World Health Organization (2022). Tuberculosis Deaths and Disease Increase during the COVID-19 Pandemic, WHO. Global Tuberculosis Report 2022."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S1473-3099(21)00808-2","article-title":"25 years of surveillance of drug-resistant tuberculosis: Achievements, challenges, and way forward","volume":"22","author":"Dean","year":"2022","journal-title":"Lancet. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kostyukova, I., Pasechnik, O., and Mokrousov, I. (2023). Epidemiology and Drug Resistance Patterns of Mycobacterium tuberculosis in High-Burden Area in Western Siberia, Russia. Microorganisms, 11.","DOI":"10.3390\/microorganisms11020425"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Khabibullina, N.F., Kutuzova, D.M., Burmistrova, I.A., and Lyadova, I.V. (2022). The Biological and Clinical Aspects of a Latent Tuberculosis Infection. Trop. Med. Infect. Dis., 7.","DOI":"10.3390\/tropicalmed7030048"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"k2738","DOI":"10.1136\/bmj.k2738","article-title":"Revisiting the timetable of tuberculosis","volume":"362","author":"Behr","year":"2018","journal-title":"Bmj"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Pawlowski, A., Jansson, M., Skold, M., Rottenberg, M.E., and Kallenius, G. (2012). Tuberculosis and HIV co-infection. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002464"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tube.2019.05.003","article-title":"Is cough really necessary for TB transmission?","volume":"117","author":"Patterson","year":"2019","journal-title":"Tuberculosis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fcimb.2019.00299","article-title":"Mycobacterium tuberculosis Primary Infection and Dissemination: A Critical Role for Alveolar Epithelial Cells","volume":"9","author":"Ryndak","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"a018192","DOI":"10.1101\/cshperspect.a018192","article-title":"Transmission and Institutional Infection Control of Tuberculosis","volume":"6","author":"Nardell","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e2013070","DOI":"10.4084\/mjhid.2013.070","article-title":"The biology of mycobacterium tuberculosis infection","volume":"5","author":"Delogu","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","article-title":"Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence","volume":"16","author":"Smith","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"747799","DOI":"10.3389\/fimmu.2022.747799","article-title":"Macrophage: A Cell With Many Faces and Functions in Tuberculosis","volume":"13","author":"Ahmad","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2018.08.001","article-title":"Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination","volume":"24","author":"Cohen","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/JLB.MR0318-095RR","article-title":"Macrophage heterogeneity and plasticity in tuberculosis","volume":"106","author":"Khan","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/mi.2011.3","article-title":"Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis","volume":"4","author":"Behar","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2012.06.010","article-title":"Efferocytosis is an innate antibacterial mechanism","volume":"12","author":"Martin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"983299","DOI":"10.3389\/fmicb.2023.983299","article-title":"Role of phagocyte extracellular traps during Mycobacterium tuberculosis infections and tuberculosis disease processes","volume":"14","author":"Meurer","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The Innate Immune Response to Mycobacterium tuberculosis Infection","volume":"39","author":"Stanley","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.drudis.2011.12.013","article-title":"Understanding latent tuberculosis: The key to improved diagnostic and novel treatment strategies","volume":"17","author":"Esmail","year":"2012","journal-title":"Drug Discov. Today"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: Success through dormancy","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2013.00120","article-title":"The role of the innate immune system in granulomatous disorders","volume":"4","author":"Petersen","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Alsayed, S.S.R., and Gunosewoyo, H. (2023). Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065202"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201000079","article-title":"Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism","volume":"2","author":"Kim","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.1628","article-title":"Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung","volume":"204","author":"Ulrichs","year":"2004","journal-title":"J. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Lee, O.Y., Wu, H.H., Donoghue, H.D., Spigelman, M., Greenblatt, C.L., Bull, I.D., Rothschild, B.M., Martin, L.D., Minnikin, D.E., and Besra, G.S. (2012). Mycobacterium tuberculosis complex lipid virulence factors preserved in the 17,000-year-old skeleton of an extinct bison, Bison antiquus. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041923"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/viru.22329","article-title":"Virulence factors of the Mycobacterium tuberculosis complex","volume":"4","author":"Forrellad","year":"2013","journal-title":"Virulence"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Biondo, C., Midiri, A., Gerace, E., Zummo, S., and Mancuso, G. (2022). SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far. Life, 12.","DOI":"10.3390\/life12122087"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Biondo, C., Ponzo, E., Midiri, A., Ostone, G.B., and Mancuso, G. (2023). The Dark Side of Nosocomial Infections in Critically Ill COVID-19 Patients. Life, 13.","DOI":"10.20944\/preprints202305.1442.v1"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ajpath.2021.03.011","article-title":"Coronavirus Activates an Altruistic Stem Cell-Mediated Defense Mechanism that Reactivates Dormant Tuberculosis: Implications in Coronavirus Disease 2019 Pandemic","volume":"191","author":"Pathak","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e0307522","DOI":"10.1128\/spectrum.03075-22","article-title":"Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis","volume":"10","author":"Hildebrand","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2102538","DOI":"10.1183\/13993003.02538-2021","article-title":"Tuberculosis and COVID-19 co-infection: Description of the global cohort","volume":"59","author":"Group","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.31083\/j.fbs1401006","article-title":"TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection","volume":"14","author":"Luke","year":"2022","journal-title":"Front. Biosci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3345\/cep.2021.01186","article-title":"Four months of rifampicin monotherapy for latent tuberculosis infection in children","volume":"65","author":"Oh","year":"2022","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_90","first-page":"1","article-title":"Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR. Recomm. Rep. Morb. Mortal. Wkly. Rep. Recomm. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13690-023-01098-z","article-title":"Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: A systematic review and network meta-analysis of randomized controlled trials","volume":"81","author":"Assefa","year":"2023","journal-title":"Arch. Public Health = Arch. Belg. De Sante Publique"},{"key":"ref_92","unstructured":"(2022). WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment\u2014Drug-Resistant Tuberculosis Treatment, 2022 Update, WHO Guidelines Approved by the Guidelines Review Committee."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: Challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat. Rev.. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1111\/bph.14867","article-title":"Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action","volume":"176","author":"Khan","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.tips.2019.10.005","article-title":"Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide","volume":"40","author":"Gopal","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.tcsw.2020.100044","article-title":"Antibiotics and resistance: The two-sided coin of the mycobacterial cell wall","volume":"6","author":"Batt","year":"2020","journal-title":"Cell Surf."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"100128","DOI":"10.1016\/j.crphar.2022.100128","article-title":"Pretomanid for tuberculosis treatment: An update for clinical purposes","volume":"3","author":"Occhineri","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO\u2019s Global Tuberculosis Report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet. Microbe"},{"key":"ref_100","first-page":"e35154","article-title":"Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now","volume":"15","author":"Chowdhury","year":"2023","journal-title":"Cureus"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Espinosa-Pereiro, J., Sanchez-Montalva, A., Aznar, M.L., and Espiau, M. (2022). MDR Tuberculosis Treatment. Medicina, 58.","DOI":"10.3390\/medicina58020188"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3201\/eid2809.220458","article-title":"Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019","volume":"28","author":"Kherabi","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/22221751.2020.1785334","article-title":"Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis","volume":"9","author":"Swain","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: Mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"612675","DOI":"10.3389\/fmicb.2021.612675","article-title":"Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment","volume":"12","author":"Garcia","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_106","first-page":"3903","article-title":"Genome-wide SNP and InDel mutations in Mycobacterium tuberculosis associated with rifampicin and isoniazid resistance","volume":"11","author":"Li","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Biondo, C. (2023). Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens, 12.","DOI":"10.3390\/pathogens12010116"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1007\/s11033-022-07404-2","article-title":"Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran","volume":"49","author":"Bakhtiyariniya","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/jobm.202100201","article-title":"Antibiotic resistance genes in bacteria: Occurrence, spread, and control","volume":"61","author":"Jian","year":"2021","journal-title":"J. Basic Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e51034","DOI":"10.15252\/embr.202051034","article-title":"Antibiotic resistance and persistence-Implications for human health and treatment perspectives","volume":"21","author":"Huemer","year":"2020","journal-title":"EMBO Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"fuab042","DOI":"10.1093\/femsre\/fuab042","article-title":"Phenotypic heterogeneity in persisters: A novel \u2018hunker\u2019 theory of persistence","volume":"46","author":"Urbaniec","year":"2022","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Lanni, A., Iacobino, A., Fattorini, L., and Giannoni, F. (2023). Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand. Microorganisms, 11.","DOI":"10.20944\/preprints202304.1233.v1"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/IDR.S144446","article-title":"Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis","volume":"10","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1027394","DOI":"10.3389\/fcimb.2022.1027394","article-title":"The evolving biology of Mycobacterium tuberculosis drug resistance","volume":"12","author":"Jones","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Hassan, S.T.S., Sudomova, M., Berchova-Bimova, K., Gowrishankar, S., and Rengasamy, K.R.R. (2018). Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations. J. Clin. Med., 7.","DOI":"10.3390\/jcm7080226"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Sudomova, M., Shariati, M.A., Echeverria, J., Berindan-Neagoe, I., Nabavi, S.M., and Hassan, S.T.S. (2019). A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases. Mar. Drugs, 17.","DOI":"10.3390\/md17110641"},{"key":"ref_117","first-page":"S12","article-title":"Update of drug-resistant tuberculosis treatment guidelines: A turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis","volume":"387","author":"Conradie","year":"2022","journal-title":"N. Engl. J. Med."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/9\/2277\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:48:24Z","timestamp":1760129304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/9\/2277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,10]]},"references-count":118,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["microorganisms11092277"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11092277","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,10]]}}}